LOS ANGELES–(BUSINESS WIRE)–The Donate Life Rose Parade® Float Celebrates 19 Years in the Rose Parade And Announces Its 2022 Float Theme, “Courage to Hope”
Category: Business
Second Sight Medical Products Announces Year Three NIH Funding of Its Orion Study
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individu…
National Vision Holdings, Inc. Reports First Quarter 2021 Financial Results; Raises Fiscal 2021 Outlook
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the first quarter ended April 3, 2021. Reade Fahs, chief executive officer, stated,“It was a truly …
National Vision Collaborates with Americares and RestoringVision to Bring Sight to Half a Million People Living in Poverty in the U.S.
DULUTH, Ga.–(BUSINESS WIRE)—- $EYE #diversity–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced today a new philanthropic collaboration with Ame…
Tilak Healthcare Launches US Pilot for OdySight Medical Vision Monitoring App
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a digital therapeutics pioneer specializing in the development of mobile medical application games used as monitoring and rehabilitation tools for chronic diseases, is launching a pilot program in the US with N…
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
MARIETTA, Ohio–(BUSINESS WIRE)—- $PKTX #AMD–ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
Case Study Series Published in Journal of Neuroscience Nursing Demonstrates NeurOptics’ Pupillometry is Key Tool for Neurological Assessment
IRVINE, Calif.–(BUSINESS WIRE)– #brain–New case study shows NeurOptics’ pupillometry provides reliable pupil reactivity measurements that may impact treatment decisions for stroke patients.
Omeros Corporation Reports First Quarter 2021 Financial Results
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications ta…
EyeSouth Partners Expands Presence in North Georgia with Georgia Eye Physicians and Surgeons Affiliation
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Georgia Eye Physicians and Surgeons (“GEPS”). The affiliation represents EyeSouth’s tenth in the state of Georgia…
Global Veterinary Eye Care Market (2021 to 2026) – Growth, Trends, and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Veterinary Eye Care Market – Growth, Trends, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. Veterinary Eye Care Market is expected to envision a CAGR of 3% during the forecast peri…
Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseas…
Global Dry Eye Epidemiology and Patient Flow Report 2021: Prevalence and Incidence and Patient by Age-Gender 2020-2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Epidemiology and Patient Flow – 2021” report has been added to ResearchAndMarkets.com’s offering. The research report, Global Dry Eye Epidemiology and Patient Flow Analysis – 2021, provides Dry Eye epidemiol…
Global Wet Age-Related Macular Degeneration Epidemiology and Patient Flow to 2035: Focus on United States, Germany, France, Italy, Spain, UK, Japan, & G7 Countries – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Wet Age-Related Macular Degeneration Epidemiology and Patient Flow – 2021” report has been added to ResearchAndMarkets.com’s offering. Global Wet Age-Related Macular Degeneration Epidemiology and Patient Flow Analys…
Global Dry Age-Related Macular Degeneration Epidemiology and Patient Flow Report 2020-2035: Identify Patient Segments Through Age Groups, Gender, and Disease Sub-types – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Age-Related Macular Degeneration Epidemiology and Patient Flow – 2021” report has been added to ResearchAndMarkets.com’s offering. Global Dry Age-Related Macular Degeneration Epidemiology and Patient Flow Analys…
Alcon Reports First Quarter 2021 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports First Quarter 2021 Results
Alcon Reports First Quarter 2021 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports First Quarter 2021 Results
Stoke Therapeutics Presents New Data That Demonstrate Tango Antisense Oligonucleotides (ASOs) Increase OPA1 Protein Production and Improve Mitochondrial Function in Cells Derived From Patients With Autosomal Dominant Optic Atrophy (ADOA)
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today announced new preclini…
Mogrify Completes Series A Financing Totaling $33 Million USD
CAMBRIDGE, England–(BUSINESS WIRE)–Mogrify Limited (Mogrify®), a biopharmaceutical company aiming to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies, announced today the second closing of…
Prime Healthcare Services, Inc. Announces Closing of $225 Million Add-on Senior Secured Notes Offering
ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services, Inc. (Prime), an award-winning national health system with 31 hospitals, announced that it has closed its public offering of $225 million Add-on senior secured credit notes – above the initia…
Precision BioSciences Announces Paper Presentation at the Association for Research in Vision and Ophthalmology 2021 Annual Meeting
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies, announced today that the following paper presentation, highlighting pre…